| Oct 25 |
Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?
|
| Oct 25 |
Stocks to watch next week: BP, Shell, Uber, HSBC and Intel
|
| Oct 24 |
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
|
| Oct 24 |
US CDC AdCom recommends lowering the age for pneumococcal vaccines
|
| Oct 24 |
Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance
|
| Oct 24 |
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
|
| Oct 24 |
Merck Keytruda cleared in EU for two new indications in gynecologic cancers
|
| Oct 24 |
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers
|
| Oct 23 |
CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older
|
| Oct 23 |
Pfizer, Merck pneumonia shots gain ACIP endorsement for wider indication
|
